JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCutcheon, R. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by McCutcheon, R. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 136, Issue 2, 209-212, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


CANINE BLOOD SUGAR AND LACTIC ACID RESPONSES TO ADRENERGIC AMINES AFTER ADRENERGIC BLOCK

Rob S. McCutcheon 1

1 Department of Pharmacology, School of Pharmacy, Oregon State University, Corvallis, Oregon

Two-hour infusions of the four amines, epinephrine, ethylnorepinephrine, Win-3046 or isoproterenol into dogs produced marked rises in blood sugar and lactic acid. If an infusion was preceded by the blocking agent phenoxybenzamine, this increase in blood sugar and lactic acid was strongly potentiated in every case. If the infusion was preceded by DCI, the production of blood sugar and lactic acid was strongly inhibited. When the same effects were measured after ergotamine, a rather indifferent block of blood sugar and lactic acid was obtained. An apparent inhibition by ergotamine occurred in each case but not all the differences were significant.

It is concluded that DCI is producing its effect here through its beta blocking ability or by blocking a special receptor for hyperglycemia; that phenoxybenzamine is not a blocking agent for blood sugar and lactic acid effects as produced in this experiment and that ergotamine is either a relatively weak blocking agent or one of mixed effect.

Submitted on December 18, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.